Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy

E-ISSN： 1875-5607|11|7|611-624

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.11, Iss.7, 2011-06, pp. : 611-624

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development for Anticancer Therapy: Small-Molecule Inhibitors Targeting Protein Kinase B

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-01 ,pp. : 1272-1294

Bentham Science Publishers

Access to resources Recommend Favorite

Development of EGFR Family Small Molecule Inhibitors for Anticancer Intervention: An Overview of Approved Drugs and Clinical Candidates

Current Medicinal Chemistry, Vol. 21, Iss. 38, 2014-12 ,pp. : 4374-4404

Bentham Science Publishers

Access to resources Recommend Favorite

Recent strategies in the development of taxane anticancer drugs

By Lin S. Ojima I.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. : 869-889

Informa Healthcare

Access to resources Recommend Favorite

Anticancer Drugs in Liposomal Nanodevices: A Target Delivery for a Targeted Therapy

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 15, 2012-08 ,pp. : 1693-1712

Bentham Science Publishers

Access to resources Recommend Favorite

The clinical development of histone deacetylase inhibitors as targeted anticancer drugs

By Marks Paul A

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 9, 2010-09 ,pp. : 1049-1066

Informa Healthcare

Access to resources Recommend Favorite